Figure 2.
Figure 2. Inhibition of NK cell-mediated killing with mAbs to ULBP on K562 cells. (A) Monoclonal antibody to ULBP2 dose-dependently inhibited the killing of GPI+ K562 cells alone. (B) Killing of GPI+ cells was inhibited with 25 μg/mL mAbs to ULBPs 1 and 2 but none of mAb to ULBP3. The mixture of mAbs to ULBPs 1 and 2 completely abolished the difference in the killing between GPI+ and GPI- cells. Each value represents the mean (± SD) of triplicate assays (E/T ratio, 16:1). □ indicates GPI+ K562 cells; ▪, GPI- K562 cells; and Control, isotype-matched control Ig. *P < .01 compared with antibody-free group.

Inhibition of NK cell-mediated killing with mAbs to ULBP on K562 cells. (A) Monoclonal antibody to ULBP2 dose-dependently inhibited the killing of GPI+ K562 cells alone. (B) Killing of GPI+ cells was inhibited with 25 μg/mL mAbs to ULBPs 1 and 2 but none of mAb to ULBP3. The mixture of mAbs to ULBPs 1 and 2 completely abolished the difference in the killing between GPI+ and GPI- cells. Each value represents the mean (± SD) of triplicate assays (E/T ratio, 16:1). □ indicates GPI+ K562 cells; ▪, GPI- K562 cells; and Control, isotype-matched control Ig. *P < .01 compared with antibody-free group.

Close Modal

or Create an Account

Close Modal
Close Modal